Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market

WASHINGTON, DC - FEBRUARY 04: Martin Shkreli, former CEO of Turing Pharmaceuticals LLC., listens to questions during a House Oversight and Government Reform Committee hearing on Capitol Hill, February 4, 2016 in Washington, DC. Shkreli invoked his 5th Amendment right not to testify to the committee that is examining the prescription drug market. (Photo by Mark Wilson/Getty Images)
WASHINGTON, DC - FEBRUARY 04: Martin Shkreli, former CEO of Turing Pharmaceuticals LLC., listens to questions during a House Oversight and Government Reform Committee hearing on Capitol Hill, February 4, 2016 in Washington, DC. Shkreli invoked his 5th Amendment right not to testify to the committee that is examining the prescription drug market. (Photo by Mark Wilson/Getty Images)
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Canada (not Quebec). Restricted editorial rights for daily newspapers elsewhere, please call.
Credit:
Mark Wilson / Staff
Editorial #:
508358470
Collection:
Getty Images News
Date created:
February 04, 2016
Upload date:
License type:
Release info:
Not released. More information
Source:
Getty Images North America
Object name:
89087304
Max file size:
3000 x 2135 px (10.00 x 7.12 in) - 300 dpi - 1 MB